Is Viking Therapeutics a Buy Now?
Shares of Viking Therapeutics (NASDAQ: VKTX), a clinical-stage biotech, more than doubled recently. The market started hurling money at the stock after some mid-stage clinical trial results suggested a bright future for its still-experimental weight management drug.
You don't need to know much about the pharmaceutical industry to recognize a huge opportunity for weight management treatments. That said, investing in biotechs before they have any approved products to sell entails a great deal of risk.
Let's weigh the opportunities in front of Viking Therapeutics against some of its challenges to see if it's a good stock now.
Source Fool.com
Viking Therapeutics Inc Stock
€62.22
-2.110%
Our community is currently high on Viking Therapeutics Inc with 5 Buy predictions and 0 Sell predictions.
With a target price of 100 € there is a hugely positive potential of 60.72% for Viking Therapeutics Inc compared to the current price of 62.22 €.
